| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $9,163,161 | 1 | 50 |
Sells | $9,163,161 | 1 | 50 |
| Pessina Stefano | Executive Chairman of Board | 1 | $9.16M | 1 | $9.16M | $0 |
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Over the last 12 months, insiders at Walgreens Boots Alliance, Inc. have bought $9.16M and sold $9.16M worth of Walgreens Boots Alliance, Inc. stock.
On average, over the past 5 years, insiders at Walgreens Boots Alliance, Inc. have bought $3.39M and sold $2.23M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Pessina Stefano (Executive Chairman of Board) — $9.16M.
The last purchase of 832,258 shares for transaction amount of $9.16M was made by Pessina Stefano (Executive Chairman of Board) on 2025‑04‑27.
| 2025-04-27 | Sale | Pessina Stefano | Executive Chairman of Board | 832,258 0.0962% | $11.01 | $9.16M | -0.73% | |
| 2025-04-27 | Pessina Stefano | Executive Chairman of Board | 832,258 0.0962% | $11.01 | $9.16M | -0.73% | ||
| 2024-04-11 | Bhandari Inderpal S | director | 3,000 0.0003% | $18.05 | $54,150 | -37.75% | ||
| 2024-04-02 | Mahajan Manmohan | EVP and Global CFO | 6,000 0.0007% | $19.38 | $116,280 | -39.89% | ||
| 2024-01-29 | JARRETT VALERIE B | director | 4,456 0.0005% | $22.44 | $99,993 | -47.71% | ||
| 2024-01-16 | Sale | SCHLICHTING NANCY M | director | 15,209 0.0018% | $23.05 | $350,567 | -47.47% | |
| 2024-01-05 | WENTWORTH TIMOTHY C | Chief Executive Officer | 10,000 0.0011% | $24.22 | $242,220 | -51.58% | ||
| 2023-11-10 | Sale | Gates Richard P. | SVP, Chief Pharmacy Officer | 1,000 0.0001% | $20.45 | $20,450 | -13.52% | |
| 2023-06-30 | DRISCOLL JOHN PATRICK | EVP, Pres. U.S. Healthcare | 5,172 0.0006% | $28.42 | $146,984 | -21.47% | ||
| 2023-03-29 | BREWER ROSALIND G | CEO | 10,000 0.0012% | $33.95 | $339,510 | -24.83% | ||
| 2022-11-18 | Sale | Ban Kevin M. | EVP, Chief Medical Officer | 10,303 0.0012% | $40.19 | $414,108 | -18.44% | |
| 2022-11-17 | Sale | SCHLICHTING NANCY M | director | 16,570 0.0019% | $39.89 | $660,928 | -19.19% | |
| 2021-11-19 | Sale | SCHLICHTING NANCY M | director | 2,725 0.0003% | $47.16 | $128,497 | -6.92% | |
| 2020-11-11 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 10,000 0.0012% | $41.55 | $415,450 | +21.49% | |
| 2019-11-05 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 468,710 0.0543% | $63.16 | $29.6M | -28.46% | |
| 2019-08-15 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 246,992 0.0272% | $50.06 | $12.36M | +3.21% | |
| 2019-08-14 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 183,654 0.0202% | $51.03 | $9.37M | +0.93% | |
| 2019-05-09 | Sale | Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 40,000 0.0044% | $53.05 | $2.12M | +0.57% | |
| 2019-04-03 | Barra Ornella | Co-Chief Operating Officer | 36,000 0.0039% | $54.56 | $1.96M | -0.93% | ||
| 2018-11-20 | Sale | SCHLICHTING NANCY M | director | 14,100 0.0015% | $78.81 | $1.11M | -29.63% |
| Pessina Stefano | Executive Chairman of Board | 145621079 16.8239% | $1.66B | 4 | 2 | +0.21% |
| Rosenstein Barry | director | 4579100 0.529% | $52.16M | 0 | 6 | |
| Barra Ornella | Co-Chief Operating Officer | 1718000 0.1985% | $19.57M | 3 | 1 | +1.3% |
| Gourlay Alexander W. | EVP and President of Walgreens | 734389 0.0848% | $8.36M | 0 | 1 | |
| WENTWORTH TIMOTHY C | Chief Executive Officer | 585122 0.0676% | $6.66M | 1 | 0 | <0.0001% |
| Fairweather George Rollo | EVP and Global CFO | 513563 0.0593% | $5.85M | 0 | 1 | |
| BREWER ROSALIND G | CEO | 369945 0.0427% | $4.21M | 1 | 0 | <0.0001% |
| Mahajan Manmohan | EVP and Global CFO | 166969 0.0193% | $1.9M | 1 | 0 | <0.0001% |
| Gates Richard P. | SVP, Chief Pharmacy Officer | 73929 0.0085% | $842,051.31 | 0 | 1 | |
| DRISCOLL JOHN PATRICK | EVP, Pres. U.S. Healthcare | 59050 0.0068% | $672,579.50 | 1 | 0 | <0.0001% |
| Wilson-Thompson Kathleen | EVP and Global Chief HRO | 55676 0.0064% | $634,149.64 | 0 | 8 | |
| Lederer John Anthony | director | 50000 0.0058% | $569,500.00 | 4 | 0 | <0.0001% |
| SABATINO THOMAS J JR | EVP, Global CLO and CAO | 44536 0.0051% | $507,265.04 | 0 | 1 | |
| Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 34700 0.004% | $395,233.00 | 0 | 5 | |
| Ban Kevin M. | EVP, Chief Medical Officer | 27916 0.0032% | $317,963.24 | 0 | 1 | |
| FOOTE WILLIAM C | director | 8207 0.0009% | $93,477.73 | 0 | 11 | |
| JARRETT VALERIE B | director | 4456 0.0005% | $50,753.84 | 1 | 0 | <0.0001% |
| Bhandari Inderpal S | director | 3000 0.0003% | $34,170.00 | 1 | 0 | <0.0001% |
| SCHAEFFER LEONARD D | director | 1512 0.0002% | $17,221.68 | 1 | 0 | <0.0001% |
| GRAHAM GINGER L | director | 2150 0.0002% | $24,488.50 | 1 | 0 | +4.11% |
| Babiak Janice M. | director | 1200 0.0001% | $13,668.00 | 2 | 0 | +2.21% |
| Murphy Ken | EVP, Chief Commercial Officer | 653 0.0001% | $7,437.67 | 0 | 1 | |
| SCHLICHTING NANCY M | director | 0 0% | $0 | 0 | 4 | |
| Scardino Kimberly R | SVP, Global Controller and CAO | 0 0% | $0 | 0 | 1 |
| Increased Positions | 391 | +34.54% | 98M | +18.22% |
| Decreased Positions | 487 | -43.02% | 109M | -20.3% |
| New Positions | 146 | New | 41M | New |
| Sold Out Positions | 167 | Sold Out | 23M | Sold Out |
| Total Postitions | 1,036 | -8.48% | 526M | -2.09% |
| Vanguard Group Inc | $947,959.00 | 9.98% | 86.34M | +2M | +2.71% | 2024-12-31 |
| Blackrock, Inc. | $667,125.00 | 7.02% | 60.76M | -12M | -16.57% | 2025-03-31 |
| State Street Corp | $472,714.00 | 4.98% | 43.05M | +54,702 | +0.13% | 2024-12-31 |
| Invesco Ltd. | $357,647.00 | 3.77% | 32.57M | +3M | +8.79% | 2024-12-31 |
| Geode Capital Management, Llc | $228,156.00 | 2.4% | 20.78M | +1M | +5.17% | 2024-12-31 |
| Morgan Stanley | $161,214.00 | 1.7% | 14.68M | +511,004 | +3.61% | 2024-12-31 |
| Ubs Group Ag | $149,460.00 | 1.57% | 13.61M | +11M | +374.96% | 2024-12-31 |
| Charles Schwab Investment Management Inc | $144,443.00 | 1.52% | 13.16M | +2M | +19.93% | 2024-12-31 |
| Goldman Sachs Group Inc | $128,232.00 | 1.35% | 11.68M | +4M | +44.6% | 2024-12-31 |
| Northern Trust Corp | $97,686.00 | 1.03% | 8.9M | +1M | +18.8% | 2024-12-31 |